Every hour, 1700 people suffer a stroke
Our software can identify high-risk patients in advance
Every year, 15 million people suffer a stroke globally, with 5 million losing their lives and another 5 million left permanently disabled. Atrial fibrillation is among the leading cardiac conditions that dramatically increase stroke risk. Therefore, millions of people are prescribed anticoagulant therapies without adequate tools to guide clinical decisions. Our cutting-edge imaging solution is transforming stroke prevention by delivering precise, data-driven insights – empowering clinicians towards truly personalized care. Our technology helps ensure the right treatment reaches the right patient at the right time, reducing unnecessary risks and improving outcomes.
Cordicity develops medical imaging software for advanced blood flow analysis from computed tomography (CT) scans of the heart. While CT cannot measure blood flow, our innovative software can processes clinical-standard CT images to retroactively calculate the full flow field – opening the door to a total new modality in the field of blood flow diagnostics.
The company is operated from Linköping, Sweden. The founding team was born out of cutting-edge research in medical image science on the international forefront. With deep roots in both engineering and clinical medicine, the team bring together a unique blend of expertise spanning over advanced cardiac imaging, biomechanical modelling, and high-performance computations. The core team—engineers, clinicians, and innovators are united by one shared mission: to bridge the gap between research and real-world impact in this important field.
The team of Cordicity AB emerged within the field of translational research in medical image science. The word translational implies that issues arise within the healthcare sector, and that the research should enhance and generate patient benefits - which now also constitutes one of the primary purposes of the company.